| Income Statement |
| Total Revenue | 24.54B |
|
| Revenues (USD) | 3.61B |
| Cost of Revenue | 17.53B |
| Gross Profit | 7.01B |
| Operating Expenses | 3.99B |
| Research and Development Expense | 548.71M |
| Selling, General and Administrative Expense | 3.44B |
| Operating Income | 3.03B |
| Dividends per Basic Common Share | 0.50 |
| Weighted Average Shares | 3.37B |
| Balance Sheet |
| Cash and Equivalents | 16.43B |
| Cash and Equivalents (USD) | 2.42B |
| Investments | 61.78B |
| Investments Current | 42.18B |
| Investments Non-Current | 19.60B |
| Trade and Non-Trade Receivables | 4.93B |
| Current Assets | 70.35B |
| Property, Plant & Equipment Net | 15.13B |
| Total Assets | 112.38B |
| Debt Current | 9.26B |
| Total Debt | 14.39B |
| Current Liabilities | 41.28B |
| Debt Non-Current | 5.13B |
| Total Liabilities | 46.80B |
| Accumulated Retained Earnings (Deficit) | 3.69B |
| Accumulated Other Comprehensive Income | -271.64M |
| Shareholders Equity | 65.52B |
| Shareholders Equity (USD) | 9.64B |
| Assets Non-Current | 42.03B |
| Total Debt (USD) | 2.12B |
| Deferred Revenue | 6.91B |
| Deposit Liabilities | 5.69B |
| Goodwill and Intangible Assets | 5.32B |
| Inventory | 2.84B |
| Liabilities Non-Current | 5.52B |
| Trade and Non-Trade Payables | 6.10B |
| Tax Liabilities | 1.43B |
| Cash Flow |
| Net Cash Flow from Financing | -3.38B |
| Net Cash Flow / Change in Cash & Cash Equivalents | -3.55B |
| Capital Expenditure | -244.84M |
| Net Cash Flow from Investing | -6.78B |
| Net Cash Flow from Operations | 6.61B |
| Effect of Exchange Rate Changes on Cash | -6.04M |